Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

BUY
N/A
10,000 New
10,000 $0
Q1 2023

May 02, 2023

BUY
N/A
1,000 Added 8.33%
13,000 $0
Q4 2022

Feb 01, 2023

SELL
N/A
-9,300 Reduced 43.66%
12,000 $0
Q3 2022

Nov 02, 2022

BUY
$0.1 - $0.75 $387 - $2,906
3,875 Added 22.24%
21,300 $1,000
Q2 2022

Aug 10, 2022

BUY
$0.3 - $2.74 $2,227 - $20,344
7,425 Added 74.25%
17,425 $9,000
Q3 2021

Nov 12, 2021

SELL
$2.1 - $5.19 $94,500 - $233,550
-45,000 Reduced 81.82%
10,000 $32,000
Q2 2021

Aug 05, 2021

SELL
$4.68 - $7.39 $618,111 - $976,034
-132,075 Reduced 70.6%
55,000 $257,000
Q1 2021

May 10, 2021

SELL
$6.81 - $10.55 $37,455 - $58,025
-5,500 Reduced 2.86%
187,075 $1.39 Million
Q4 2020

Jan 29, 2021

BUY
$3.33 - $7.18 $75,258 - $162,268
22,600 Added 13.3%
192,575 $1.38 Million
Q3 2020

Nov 10, 2020

BUY
$2.74 - $3.62 $52,745 - $69,685
19,250 Added 12.77%
169,975 $561,000
Q2 2020

Aug 13, 2020

BUY
$3.07 - $4.68 $121,265 - $184,860
39,500 Added 35.51%
150,725 $517,000
Q1 2020

May 11, 2020

BUY
$2.28 - $6.6 $20,520 - $59,400
9,000 Added 8.8%
111,225 $412,000
Q4 2019

Feb 07, 2020

SELL
$3.34 - $5.51 $34,736 - $57,304
-10,400 Reduced 9.23%
102,225 $479,000
Q3 2019

Nov 08, 2019

BUY
$2.23 - $4.61 $41,366 - $85,515
18,550 Added 19.72%
112,625 $362,000
Q2 2019

Aug 08, 2019

BUY
$3.59 - $8.37 $91,993 - $214,481
25,625 Added 37.44%
94,075 $388,000
Q1 2019

May 10, 2019

SELL
$7.71 - $11.24 $6,168 - $8,992
-800 Reduced 1.16%
68,450 $550,000
Q4 2018

Feb 11, 2019

SELL
$7.3 - $18.3 $7,300 - $18,300
-1,000 Reduced 1.42%
69,250 $506,000
Q3 2018

Nov 09, 2018

SELL
$9.77 - $17.15 $108,447 - $190,364
-11,100 Reduced 13.64%
70,250 $1.18 Million
Q2 2018

Aug 10, 2018

BUY
$5.43 - $9.83 $5,973 - $10,813
1,100 Added 1.37%
81,350 $767,000
Q1 2018

May 15, 2018

BUY
$5.79 - $8.86 $75,849 - $116,065
13,100 Added 19.51%
80,250 $477,000
Q4 2017

Feb 15, 2018

BUY
$5.88 - $9.09 $137,886 - $213,160
23,450 Added 53.66%
67,150 $520,000
Q3 2017

Nov 13, 2017

BUY
$7.55 - $9.43 $329,935 - $412,091
43,700
43,700 $374,000

About Endo International plc


  • Ticker ENDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 235,143,008
  • Market Cap $68.8M
  • Description
  • Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...
More about ENDP
Track This Portfolio

Track Hunter Associates Investment Management LLC Portfolio

Follow Hunter Associates Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hunter Associates Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hunter Associates Investment Management LLC with notifications on news.